The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Infectious Disease Testing Using PCR for IVD Market Research Report 2024

Global Infectious Disease Testing Using PCR for IVD Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1897049

No of Pages : 99

Ask Your Query
Synopsis
The introduction of available in vitro diagnostic (IVD) PCR assays into the clinical microbiology laboratory has facilitated enhancements to patient care, improving diagnostic sensitivity and specificity.
The global Infectious Disease Testing Using PCR for IVD market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Infectious Disease Testing Using PCR for IVD is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Infectious Disease Testing Using PCR for IVD is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Infectious Disease Testing Using PCR for IVD include Thermo Fisher, BD, Roche Diagnostics, Merck, Siemens Healthineers, Hologic, Abbott Laboratories, BioMerieux and Cepheid, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Testing Using PCR for IVD, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Testing Using PCR for IVD.
Report Scope
The Infectious Disease Testing Using PCR for IVD market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Testing Using PCR for IVD market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Testing Using PCR for IVD manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
BD
Roche Diagnostics
Merck
Siemens Healthineers
Hologic
Abbott Laboratories
BioMerieux
Cepheid
Bayer
Sysmex
Ortho Clinical Diagnostics
Qiagen
Codexis
Bio-Rad Laboratories
Oxford Nanopore
Segment by Type
Direct Detection
Indirect Detection
Segment by Application
Hospitals
Laboratory
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Infectious Disease Testing Using PCR for IVD manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Infectious Disease Testing Using PCR for IVD in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Infectious Disease Testing Using PCR for IVD Market Overview
1.1 Product Overview and Scope of Infectious Disease Testing Using PCR for IVD
1.2 Infectious Disease Testing Using PCR for IVD Segment by Type
1.2.1 Global Infectious Disease Testing Using PCR for IVD Market Value Comparison by Type (2024-2030)
1.2.2 Direct Detection
1.2.3 Indirect Detection
1.3 Infectious Disease Testing Using PCR for IVD Segment by Application
1.3.1 Global Infectious Disease Testing Using PCR for IVD Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Laboratory
1.3.4 Other
1.4 Global Infectious Disease Testing Using PCR for IVD Market Size Estimates and Forecasts
1.4.1 Global Infectious Disease Testing Using PCR for IVD Revenue 2019-2030
1.4.2 Global Infectious Disease Testing Using PCR for IVD Sales 2019-2030
1.4.3 Global Infectious Disease Testing Using PCR for IVD Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Infectious Disease Testing Using PCR for IVD Market Competition by Manufacturers
2.1 Global Infectious Disease Testing Using PCR for IVD Sales Market Share by Manufacturers (2019-2024)
2.2 Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Infectious Disease Testing Using PCR for IVD Average Price by Manufacturers (2019-2024)
2.4 Global Infectious Disease Testing Using PCR for IVD Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Infectious Disease Testing Using PCR for IVD, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Infectious Disease Testing Using PCR for IVD, Product Type & Application
2.7 Infectious Disease Testing Using PCR for IVD Market Competitive Situation and Trends
2.7.1 Infectious Disease Testing Using PCR for IVD Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Infectious Disease Testing Using PCR for IVD Players Market Share by Revenue
2.7.3 Global Infectious Disease Testing Using PCR for IVD Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Infectious Disease Testing Using PCR for IVD Retrospective Market Scenario by Region
3.1 Global Infectious Disease Testing Using PCR for IVD Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Infectious Disease Testing Using PCR for IVD Global Infectious Disease Testing Using PCR for IVD Sales by Region: 2019-2030
3.2.1 Global Infectious Disease Testing Using PCR for IVD Sales by Region: 2019-2024
3.2.2 Global Infectious Disease Testing Using PCR for IVD Sales by Region: 2025-2030
3.3 Global Infectious Disease Testing Using PCR for IVD Global Infectious Disease Testing Using PCR for IVD Revenue by Region: 2019-2030
3.3.1 Global Infectious Disease Testing Using PCR for IVD Revenue by Region: 2019-2024
3.3.2 Global Infectious Disease Testing Using PCR for IVD Revenue by Region: 2025-2030
3.4 North America Infectious Disease Testing Using PCR for IVD Market Facts & Figures by Country
3.4.1 North America Infectious Disease Testing Using PCR for IVD Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Infectious Disease Testing Using PCR for IVD Sales by Country (2019-2030)
3.4.3 North America Infectious Disease Testing Using PCR for IVD Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Infectious Disease Testing Using PCR for IVD Market Facts & Figures by Country
3.5.1 Europe Infectious Disease Testing Using PCR for IVD Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Infectious Disease Testing Using PCR for IVD Sales by Country (2019-2030)
3.5.3 Europe Infectious Disease Testing Using PCR for IVD Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Infectious Disease Testing Using PCR for IVD Market Facts & Figures by Country
3.6.1 Asia Pacific Infectious Disease Testing Using PCR for IVD Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Infectious Disease Testing Using PCR for IVD Sales by Country (2019-2030)
3.6.3 Asia Pacific Infectious Disease Testing Using PCR for IVD Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Infectious Disease Testing Using PCR for IVD Market Facts & Figures by Country
3.7.1 Latin America Infectious Disease Testing Using PCR for IVD Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Infectious Disease Testing Using PCR for IVD Sales by Country (2019-2030)
3.7.3 Latin America Infectious Disease Testing Using PCR for IVD Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Infectious Disease Testing Using PCR for IVD Market Facts & Figures by Country
3.8.1 Middle East and Africa Infectious Disease Testing Using PCR for IVD Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Infectious Disease Testing Using PCR for IVD Sales by Country (2019-2030)
3.8.3 Middle East and Africa Infectious Disease Testing Using PCR for IVD Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Infectious Disease Testing Using PCR for IVD Sales by Type (2019-2030)
4.1.1 Global Infectious Disease Testing Using PCR for IVD Sales by Type (2019-2024)
4.1.2 Global Infectious Disease Testing Using PCR for IVD Sales by Type (2025-2030)
4.1.3 Global Infectious Disease Testing Using PCR for IVD Sales Market Share by Type (2019-2030)
4.2 Global Infectious Disease Testing Using PCR for IVD Revenue by Type (2019-2030)
4.2.1 Global Infectious Disease Testing Using PCR for IVD Revenue by Type (2019-2024)
4.2.2 Global Infectious Disease Testing Using PCR for IVD Revenue by Type (2025-2030)
4.2.3 Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Type (2019-2030)
4.3 Global Infectious Disease Testing Using PCR for IVD Price by Type (2019-2030)
5 Segment by Application
5.1 Global Infectious Disease Testing Using PCR for IVD Sales by Application (2019-2030)
5.1.1 Global Infectious Disease Testing Using PCR for IVD Sales by Application (2019-2024)
5.1.2 Global Infectious Disease Testing Using PCR for IVD Sales by Application (2025-2030)
5.1.3 Global Infectious Disease Testing Using PCR for IVD Sales Market Share by Application (2019-2030)
5.2 Global Infectious Disease Testing Using PCR for IVD Revenue by Application (2019-2030)
5.2.1 Global Infectious Disease Testing Using PCR for IVD Revenue by Application (2019-2024)
5.2.2 Global Infectious Disease Testing Using PCR for IVD Revenue by Application (2025-2030)
5.2.3 Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Application (2019-2030)
5.3 Global Infectious Disease Testing Using PCR for IVD Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Corporation Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Infectious Disease Testing Using PCR for IVD Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BD Infectious Disease Testing Using PCR for IVD Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Roche Diagnostics
6.3.1 Roche Diagnostics Corporation Information
6.3.2 Roche Diagnostics Description and Business Overview
6.3.3 Roche Diagnostics Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Diagnostics Infectious Disease Testing Using PCR for IVD Product Portfolio
6.3.5 Roche Diagnostics Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Infectious Disease Testing Using PCR for IVD Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Siemens Healthineers
6.5.1 Siemens Healthineers Corporation Information
6.5.2 Siemens Healthineers Description and Business Overview
6.5.3 Siemens Healthineers Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Siemens Healthineers Infectious Disease Testing Using PCR for IVD Product Portfolio
6.5.5 Siemens Healthineers Recent Developments/Updates
6.6 Hologic
6.6.1 Hologic Corporation Information
6.6.2 Hologic Description and Business Overview
6.6.3 Hologic Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hologic Infectious Disease Testing Using PCR for IVD Product Portfolio
6.6.5 Hologic Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Laboratories Infectious Disease Testing Using PCR for IVD Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 BioMerieux
6.8.1 BioMerieux Corporation Information
6.8.2 BioMerieux Description and Business Overview
6.8.3 BioMerieux Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BioMerieux Infectious Disease Testing Using PCR for IVD Product Portfolio
6.8.5 BioMerieux Recent Developments/Updates
6.9 Cepheid
6.9.1 Cepheid Corporation Information
6.9.2 Cepheid Description and Business Overview
6.9.3 Cepheid Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cepheid Infectious Disease Testing Using PCR for IVD Product Portfolio
6.9.5 Cepheid Recent Developments/Updates
6.10 Bayer
6.10.1 Bayer Corporation Information
6.10.2 Bayer Description and Business Overview
6.10.3 Bayer Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bayer Infectious Disease Testing Using PCR for IVD Product Portfolio
6.10.5 Bayer Recent Developments/Updates
6.11 Sysmex
6.11.1 Sysmex Corporation Information
6.11.2 Sysmex Infectious Disease Testing Using PCR for IVD Description and Business Overview
6.11.3 Sysmex Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sysmex Infectious Disease Testing Using PCR for IVD Product Portfolio
6.11.5 Sysmex Recent Developments/Updates
6.12 Ortho Clinical Diagnostics
6.12.1 Ortho Clinical Diagnostics Corporation Information
6.12.2 Ortho Clinical Diagnostics Infectious Disease Testing Using PCR for IVD Description and Business Overview
6.12.3 Ortho Clinical Diagnostics Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ortho Clinical Diagnostics Infectious Disease Testing Using PCR for IVD Product Portfolio
6.12.5 Ortho Clinical Diagnostics Recent Developments/Updates
6.13 Qiagen
6.13.1 Qiagen Corporation Information
6.13.2 Qiagen Infectious Disease Testing Using PCR for IVD Description and Business Overview
6.13.3 Qiagen Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Qiagen Infectious Disease Testing Using PCR for IVD Product Portfolio
6.13.5 Qiagen Recent Developments/Updates
6.14 Codexis
6.14.1 Codexis Corporation Information
6.14.2 Codexis Infectious Disease Testing Using PCR for IVD Description and Business Overview
6.14.3 Codexis Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Codexis Infectious Disease Testing Using PCR for IVD Product Portfolio
6.14.5 Codexis Recent Developments/Updates
6.15 Bio-Rad Laboratories
6.15.1 Bio-Rad Laboratories Corporation Information
6.15.2 Bio-Rad Laboratories Infectious Disease Testing Using PCR for IVD Description and Business Overview
6.15.3 Bio-Rad Laboratories Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Bio-Rad Laboratories Infectious Disease Testing Using PCR for IVD Product Portfolio
6.15.5 Bio-Rad Laboratories Recent Developments/Updates
6.16 Oxford Nanopore
6.16.1 Oxford Nanopore Corporation Information
6.16.2 Oxford Nanopore Infectious Disease Testing Using PCR for IVD Description and Business Overview
6.16.3 Oxford Nanopore Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Oxford Nanopore Infectious Disease Testing Using PCR for IVD Product Portfolio
6.16.5 Oxford Nanopore Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Infectious Disease Testing Using PCR for IVD Industry Chain Analysis
7.2 Infectious Disease Testing Using PCR for IVD Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Infectious Disease Testing Using PCR for IVD Production Mode & Process
7.4 Infectious Disease Testing Using PCR for IVD Sales and Marketing
7.4.1 Infectious Disease Testing Using PCR for IVD Sales Channels
7.4.2 Infectious Disease Testing Using PCR for IVD Distributors
7.5 Infectious Disease Testing Using PCR for IVD Customers
8 Infectious Disease Testing Using PCR for IVD Market Dynamics
8.1 Infectious Disease Testing Using PCR for IVD Industry Trends
8.2 Infectious Disease Testing Using PCR for IVD Market Drivers
8.3 Infectious Disease Testing Using PCR for IVD Market Challenges
8.4 Infectious Disease Testing Using PCR for IVD Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock